Background
==========

Infertility is a major problem in 15% of couples worldwide. Male factors may play a role in half of these cases \[[@B1]\]. Most causes of male infertility are idiopathic. Semen analysis remains the cornerstone in the evaluation of male infertility. However, the data generated from this routine testing do not provide any insight into the underlying problems associated with developing spermatozoa. Sperm morphology plays an important role in conception, and both fertilization and pregnancy rates are affected when morphologically normal sperms are below 5%. It is also a reflection of poor testicular physiology and is an important factor in male infertility \[[@B2]-[@B4]\]. However, a significant overlap of semen parameters such as sperm count, motility and morphology have been documented \[[@B5]\]. Idiopathic and unexplained infertility cannot be diagnosed by routine sperm function tests \[[@B6]\]. Similarly, oligozoospermic men may have other underlying pathologies that may contribute to infertility. Evaluation solely based on semen analysis is insufficient to determine the fertility status of the male partner.

Spermatogenesis is a complex process that involves development of the undifferentiated germ cells into a highly specialized spermatozoon capable of fertilizing an oocyte \[[@B7]\]. Fertilization requires physical proximity of the spermatozoa and the oocytes. Seminal plasma composed of secretions from the testis, epididymis and male accessory glands \[[@B8]\] provides a favorable environment and serves as a vehicle for the spermatozoa as it travels to meet the oocyte.

Seminal plasma contains unique proteins necessary for sperm function and survival \[[@B9],[@B10]\]. Seminal plasma proteins play a variety of roles---they help protect the sperm by binding to the sperm surface during ejaculation and play a key role in capacitation, acrosome reaction, and sperm-egg fusion \[[@B11],[@B12]\]. They can also modulate immune response in male and female reproductive tracts, ensuring that the most competent spermatozoa meet the oocyte during fertilization \[[@B13]\]. Thus, seminal plasma proteins can serve as important biomarkers for male infertility \[[@B14]\].

Conventional 1-Dimensional gel electrophoresis studies have provided information in relation to sperm proteins and their function in normal and abnormal spermatozoa \[[@B15],[@B16]\]. Advancements in mass- spectrometry and proteomic-based techniques have made it possible to analyze the complex protein mixtures found in tissues and body fluids. Several attempts have been made to identify these proteins using high-throughput techniques such as matrix assisted laser desorption ionization -- time of flight (MALDI-TOF) mass spectrometry (MS) and liquid chromatography -- tandem mass spectrometry (LC-MS/MS) and linear ion trap (LTQ-Orbitrap) mass spectrometry \[[@B17]-[@B21]\].

Alterations at the molecular level in spermatozoa and the seminal plasma may contribute to male infertility. However, even after accounting for all the advances in proteomics, there has been a great lack of detailed data in the area of comparative analysis of seminal plasma proteins associated with male infertility.

The objective of the present study was 1) to compare the differential expression of proteins in the seminal plasma from subjects with normal or abnormal sperm concentration and sperm morphology utilizing proteomic tools such as LC-MS/MS and 2) utilize the functional bioinformatics analysis to identify the cellular origin and the differentially affected processes and/or pathways of these proteins to gain insights into the mechanistic roles played by these proteins in effecting the observed phenotypes. These analyses could possibly identify potential biomarkers for male infertility.

Methods
=======

After obtaining Institutional Review Board approval, written consent was obtained from all subjects. Semen samples were obtained from 64 subjects who were healthy male volunteers of unproven fertility (n = 21) and men presenting to our infertility clinic for evaluation (n = 43). Semen samples were collected by masturbation after 2--3 days of sexual abstinence. Samples with leukocytospermia\--a high concentration of white blood cells (\>1 × 10^6^ WBC/mL)\--were examined for the presence of granulocytes by the peroxidase or the Endtz test. The patients with a positive Endtz test were excluded from the study. Semen analysis was conducted according to WHO criteria as described below \[[@B22]\].

Semen analysis
--------------

Following complete liquefaction (average time: 20 minutes and no more than 60 min.), manual semen analysis was performed using a MicroCell counting chamber (Vitrolife, San Diego, CA) to determine sperm concentration and percentage motility according to WHO guidelines \[[@B22]\]. Viability was determined with Eosin - Nigrosin stain. Smears of the raw semen were stained with a Diff-Quik kit (Baxter Healthcare Corporation, Inc., McGaw Park, IL) for assessment of sperm morphology according to WHO criteria \[[@B22]\].

After analysis of semen parameters, aliquots of the samples were frozen at −80°C for proteomic analysis.

Preparation of samples for proteomic analysis
---------------------------------------------

Samples were divided into 4 groups based only on normal sperm concentration and normal morphology parameters according to WHO criteria \[[@B22]\]. The groups were as follows: Group 1: normal sperm count and normal morphology (NN = 26); Group 2: normal sperm count and abnormal morphology (NA = 22); Group 3: oligozoospermia and normal morphology (ON = 6) and group 4: oligozoospermia and abnormal morphology (OA = 10).

To prepare the samples for proteomic analysis, they were thawed, and clear seminal plasma was separated from the sperm pellet by centrifugation at 3,000 g for 30 minutes to ensure complete removal of the cellular components. Seminal plasma samples were pooled into replicates (NN = 5; NA = 4; ON = 1; OA = 2). Each sample was dissolved in 98% acetonitrile containing 0.1% trifluoroacetic acid followed by lyophilization at −80°C under vacuum for 2 days. The lyophilized sample was used to estimate the protein content. The samples were first precipitated in cold acetone and centrifuged at 10,000 g for 15 minutes. The acetone was poured off, and the protein pellet was allowed to dry at room temperature. The protein pellet was solubilized in a buffer of 6 M urea, 100 mM Tris, pH 8.0. The proteins were then reduced by the addition of DTT (200 mM in 100 mM Tris) for 15 minutes at room temperature and then alkylated by the addition of 200 mM iodoacetamide (200 mM in 100 mM Tris) for 20 minutes at room temperature. The urea concentration was then reduced to approximately 1.2 M, and trypsin was added at a ratio of 1:50. Digestion was carried out overnight at room temperature. The digestion was stopped the next morning by adding acetic acid to lower the pH to \<6, and the samples were centrifuged to remove insoluble material. The digests were then prepared for LC-MS/MS analysis by using PepClean C-18 spin columns to desalt the samples, which were then brought up in 50 μL of 1% acetic acid.

Liquid chromatography -- mass spectrometer analysis (LC-MS/MS)
--------------------------------------------------------------

The LC-MS system is a Finnigan LTQ linear ion trap mass spectrometer system. The high performance liquid chromatography (HPLC) column was a self-packed 9 cm × 75 μm (internal diameter) Phenomenex Jupiter C18 reversed-phase capillary chromatography column. Ten μL volumes of the extract were injected, and the peptides that were eluted from the column by an acetonitrile/0.1% formic acid gradient at a flow rate of 0.25 μL/min were introduced into the source of the mass spectrometer on-line. The microelectrospray ion source was set at 2.5 kV. The digest was analyzed using the data-dependent multitask capability of the instrument acquiring full scan mass spectra to determine peptide molecular weights and product ion spectra to determine the amino acid sequence in successive instrument scans \[[@B23]\]. This mode of analysis produces approximately 2500 collision-induced dissociation (CID) spectra of ions ranging in abundance over several orders of magnitude. The spectral count (SC) for each protein was determined. Normalized spectral count (NSC) was obtained by dividing the spectral count for each protein and the total number of spectral counts identified in the sample. The spectral counts were quantitated by taking the normalized spectral count ratio for two sets of samples. A protein was considered to be differentially expressed if there was at least a two-fold difference in the spectral count ratios between the two samples.

Data analysis
-------------

All CID spectra collected in the experiment were used to search the National Center for Biotechnology Information (NCBI) human reference sequence database with the search engine MASCOT (Matrix Science, Boston, MA, <http://www.matrixscience.com>). After identification, a database consisting of all proteins identified in these searches was created and used for a second set of searches. These searches were performed with a program called SEQUEST, and the results from these SEQUEST searches were used to determine the spectral counts. Furthermore, functional bioinformatics analysis was done using publicly available software packages such as Gene Ontology annotations from GO Term Finder \[[@B24]\] and GO Term Mapper \[[@B25]\], UniProt \[[@B26]\], STRAP \[[@B27]\], and BioGPS \[[@B28]\]) as well as proprietary software packages (Ingenuity Pathway Analysis (IPA) from Ingenuity® Systems \[[@B29]\], and Metacore™ from GeneGo Inc. \[[@B30]\]) to identify the differentially affected processes, pathways, interactions, and cellular distribution of the proteins in the four study groups.

Results
=======

Analysis of the proteins identified by LC-MS/MS
-----------------------------------------------

The proteins identified in the 12 replicates from NN, NA, ON and OA group showing protein name, NCBI database index, molecular weight, peptide coverage and Mascot score is shown in Table [1](#T1){ref-type="table"}. A protein was considered significant if the SC cut off value was ≥ 10 in at least one sample and present in at least 50% of the samples in a group. They were considered 'low abundant' if the SC cut-off value was ≤10 in all the samples. The differentially expressed proteins (DEP) in the NA, OA, and ON groups were categorized based on the NSC ratio cut-off values of \> 2 (for over-expressed) or \< 0.5 (for under-expressed) in comparison to the NN group. We identified a total of 35 proteins; of these, 10 were classified as low abundant. Amongst the remaining 25 significantly abundant proteins (24 in NN, 23 in NA, 20 in OA, and 16 in ON), 11 were present in all the samples, and 13 proteins were identified as unique to one or two or three of the four samples. 20 proteins were identified as differentially expressed in the NA, OA, and ON groups as compared to NN group, with 2 proteins differentially expressed in all three groups (Figure [1](#F1){ref-type="fig"}). The remaining 18 were present in either of the groups (Figure [2](#F2){ref-type="fig"}). A detailed list of the proteins classified under these categories (Common, Unique, Significant, Low Abundant, and Differentially Expressed) is shown in Table [2](#T2){ref-type="table"}.

###### 

Identification of proteins in the 12 replicates from NN, NA, ON and OA group showing protein name, NCBI database index, molecular weight, peptide coverage and Mascot score

  **Identification**                                                         **LTQ**                           
  ------------------------------------------------------------------------ ----------- ----- ----- ----------- -------
  **Sample NN1**                                                                                               
  semenogelin II precursor                                                   4506885    65     9     8(10%)     9536
  prolactin induced protein                                                  4505821    16    8.2    3(20%)     5335
  albumin preproprotein                                                      4502027    71    5.9    9(22%)     4805
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    3 (21%)     794
  prosaposin isoform a preproprotein                                        11386147    59     5     1 (2%)      658
  mucin 6, gastric                                                          151301154   263   7.2    4 (3%)      461
  prostate specific antigen isoform 4 preproprotein                         71834855    24     7     3 (15%)     460
  armadillo repeat protein                                                   4502247    105   6.3     3(5%)      413
  cathepsin D preproprotein                                                  4503143    45    6.1    1 (4%)      285
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    2 (12%)     260
  cystatin S precursor                                                       4503109    16    4.9    2 (31%)     178
  ubiquitin and ribosomal protein S27a precursor                             4506713    18    9.6    1 (10%)     173
  clusterin isoform 1                                                       42716297    58    6.2    3 (10%)     142
  **Sample NN2**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2   10 (69%)    32886
  semenogelin II precursor                                                   4506885    65     9    17 (33%)    22468
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   13 (33%)    5388
  albumin preproprotein                                                      4502027    71    5.9   24 (54%)    15508
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   11 (61%)    5087
  lactotransferrin precursor                                                54607120    80    8.5   22 (42%)    4281
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7   11 (44%)    3424
  cystatin S precursor                                                       4503109    16    4.9    5 (44%)    1809
  prosaposin isoform a preproprotein                                        11386147    59     5     9 (33%)     880
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    4 (52%)     786
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3   11 (48%)     737
  mucin 6, gastric                                                          151301154   263   7.2    11 (9%)     524
  extracellular matrix protein 1 isoform 1 precursor                        221316614   62    6.2    7 (31%)     504
  cystatin C precursor                                                       4503107    16     9     6 (68%)     432
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    4 (40%)     411
  fibronectin 1 isoform 3 preproprotein                                     16933542    262   5.4    8(11%)      353
  cathepsin D preproprotein                                                  4503143    45    6.1    3 (11%)     266
  acid phosphatase, prostate short isoform precursor                         6382064    44    5.8    2 (12%)     166
  carboxypeptidase E preproprotein                                           4503009    53     5     5 (20%)     153
  clusterin isoform 1                                                       42716297    58    6.2    2 (7%)      106
  **Sample NN3**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2   10 (66%)    24697
  semenogelin II precursor                                                   4506885    65     9    19 (35%)    13533
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   15 (39%)    2633
  albumin preproprotein                                                      4502027    71    5.9   30 (60%)    8842
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   16 (70%)    8634
  lactotransferrin precursor                                                54607120    80    8.5   23 (49%)    4607
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    9 (42%)    3935
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    6 (52%)    1214
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    3 (29%)     987
  prosaposin isoform a preproprotein                                        11386147    59     5     5 (21%)     833
  extracellular matrix protein 1 isoform 1 precursor                        221316614   62    6.2    6 (22%)     766
  cystatin S precursor                                                       4503109    16    4.9    5 (49%)     621
  beta 2 microglobulin precursor                                             4757826    13     6     2 (21%)     523
  fibronectin 1 isoform 3 preproprotein                                     16933542    262   5.4    4 (2%)      410
  orosomucoid 1 precursor                                                   167857790   23     5     3 (16%)     397
  cystatin C precursor                                                       4503107    16     9     3 (26%)     301
  mucin 6, gastric                                                          151301154   263   7.2    7 (7%)      288
  cathepsin D preproprotein                                                  4503143    45    6.1    2 (11%)     228
  carboxypeptidase E preproprotein                                           4503009    53     5     3 (16%)     193
  acidic epididymal glycoprotein-like 1 isoform 1 precursor                 25121982    29    5.5    2 (10%)     166
  galectin 3 binding protein                                                 5031863    66    5.1    4 (11%)     165
  clusterin isoform 1                                                       42716297    58    6.2    2 (7%)      158
  acid phosphatase, prostate short isoform precursor                         6382064    44    5.8    5 (16%)     128
  prostaglandin (H2) D-isomerase −1 peptide                                 32171249    21    7.6    1 (8%)      115
  **Sample NN4**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2   12 (76%)    36052
  semenogelin II precursor                                                   4506885    65     9    16 (32%)    17746
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   14 (34%)    2723
  lactotransferrin precursor                                                54607120    80    8.5   39 (61%)    8695
  albumin preproprotein                                                      4502027    71    5.9   23 (48%)    8361
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   15 (67%)    7417
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7   11 (38%)    3979
  mucin 6, gastric                                                          151301154   263   7.2   14 (12%)    1685
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    7 (70%)    1428
  acid phosphatase, prostate short isoform precursor                         6382064    44    5.8    9 (26%)    1384
  clusterin isoform 1                                                       42716297    58    6.2    6 (16%)    1148
  orosomucoid 1 precursor                                                   167857790   23     5     4 (32%)     942
  orosomucoid 2                                                              4505529    23     5     2 (12%)     207
  prosaposin isoform a preproprotein                                        11386147    59     5     6 (27%)     941
  extracellular matrix protein 1 isoform 1 precursor                        221316614   62    6.2    7 (25%)     731
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    3 (29%)     635
  beta 2 microglobulin precursor                                             4757826    13     6     2 (21%)     489
  fibronectin 1 isoform 3 preproprotein                                     16933542    262   5.4    4 (3%)      447
  cystatin C precursor                                                       4503107    16     9     3 (26%)     391
  carboxypeptidase E preproprotein                                           4503009    53     5     4 (14%)     358
  galectin 3 binding protein                                                 5031863    66    5.1    5 (14%)     341
  transferrin                                                                4557871    79    6.8    2 (4%)      275
  acidic epididymal glycoprotein-like 1 isoform 1 precursor                 25121982    29    5.5    2 (10%)     238
  cystatin S precursor                                                       4503109    16    4.9    2 (20%)     205
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3    3 (12%)     187
  cathepsin D preproprotein                                                  4503143    45    6.1    2 (11%)     185
  prostaglandin (H2) D-isomerase −1 peptide                                 32171249    21    7.6    1 (8%)      133
  **Sample NN5**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2    8 (44%)    15001
  semenogelin II precursor                                                   4506885    65     9    10 (14%)    7235
  albumin preproprotein                                                      4502027    71    5.9   17 (39%)    2621
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    3 (23%)     552
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6    5 (22%)     539
  cystatin S precursor                                                       4503109    16    4.9    2 (23%)     332
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    4 (19%)     250
  prosaposin isoform a preproprotein                                        11386147    59     5     1 (2%)      239
  prostatic acid phosphatase precursor                                       6382064    44    5.8    2 (4%)      180
  lactotransferrin                                                          54607120    80    8.5    4 (10%)     173
  clusterin isoform 1                                                       42716297    58    6.2    2 (7%)      157
  galectin 3 binding protein                                                 5031863    66    5.1    2 (4%)      152
  extracellular matrix protein 1 isoform 1 precursor                         4758236    62    6.2    1 (5%)      119
  **Sample NA1**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2   10 (62%)    17127
  albumin preproprotein                                                      4502027    71    5.9   36 (61%)    9157
  semenogelin II precursor                                                   4506885    65     9    22 (39%)    7469
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   19 (42%)    2622
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   14 (67%)    5287
  lactotransferrin                                                          54607120    80    8.5   19 (40%)    2696
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    9 (38%)    1904
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    6 (68%)    1228
  extracellular matrix protein 1 isoform 1 precursor                        221316614   62    6.2    6 (22%)     635
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3    8 (27%)     616
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    2 (19%)     487
  prosaposin isoform a preproprotein                                        11386147    59     5     4 (15%)     475
  beta 2 microglobulin precursor                                             4757826    13     6     2 (21%)     400
  fibronectin 1 isoform 3 preproprotein                                     16933542    262   5.4    7 (5%)      398
  cystatin C precursor                                                       4503107    16     9     3 (26%)     340
  cystatin S precursor                                                       4503109    16    4.9    2 (20%)     261
  mucin 6, gastric isoform 1                                                89033736    185   6.3    4 (5%)      238
  prostaglandin (H2) D-isomerase                                            32171249    21    7.6    1 (8%)      227
  prostatic acid phosphatase precursor                                       6382064    44    5.8    4 (8%)      189
  protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor    104487006   218   6.1    5 (5%)      180
  transferrin                                                                4557871    79    6.8    3 (17%)     174
  clusterin isoform 1                                                       42716297    58    6.2    4 (11%)     171
  cathepsin D preproprotein                                                  4503143    45    6.1    1 (4%)      149
  galectin 3 binding protein                                                 5031863    66    5.1    5 (14%)     101
  **Sample NA2**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2   12 (76%)    21197
  semenogelin II precursor                                                   4506885    65     9    18 (36%)    9137
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   13 (33%)    1777
  albumin preproprotein                                                      4502027    71    5.9   26 (55%)    7695
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   16 (67%)    4963
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7   13 (44%)    3134
  lactotransferrin                                                          54607120    80    8.5   24 (46%)    3105
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    5 (68%)    1276
  prosaposin isoform a preproprotein                                        11386147    59     5     7 (26%)     662
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    3 (29%)     660
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3    5 (20%)     612
  extracellular matrix protein 1 isoform 1 precursor                         4758236    62    6.2    7 (22%)     577
  cystatin C precursor                                                       4503107    16     9     3 (26%)     548
  beta 2 microglobulin precursor                                             4757826    13     6     2 (21%)     443
  prostatic acid phosphatase precursor                                       6382064    44    5.8    8 (18%)     410
  cathepsin D preproprotein                                                  4503143    45    6.1    5 (25%)     375
  clusterin isoform 1                                                       42716297    58    6.2    2 (7%)      308
  DJ-1 protein                                                              31543380    20    6.3    2 (26%)     279
  carboxypeptidase E preproprotein                                           4503009    53     5     4 (19%)     278
  galectin 3 binding protein                                                 5031863    66    5.1    5 (14%)     266
  cystatin S precursor                                                       4503109    16    4.9    6 (64%)     212
  CD177 molecule                                                            110735433   47    5.6    2 (9%)      199
  mucin 6, gastric isoform 1                                                89033736    185   6.3    3 (4%)      196
  fibronectin 1 isoform 3 preproprotein                                     16933542    262   5.4    4 (4%)      172
  secretory leukocyte peptidase inhibitor precursor                          4507065    15    9.1    2 (28%)     162
  cathepsin B preproprotein                                                  4503139    38    5.8    3 (12%)     127
  **Sample NA3**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2    5 (37%)    6642
  semenogelin II precursor                                                   4506885    65     9     6 (9%)     5126
  albumin preproprotein                                                      4502027    71    5.9    7 (17%)    2077
  prosaposin isoform a preproprotein                                        11386147    59     5     2 (8%)      438
  mucin 6, gastric isoform 1                                                89033736    185   6.3    3 (2%)      269
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    2 (21%)     210
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    3 (24%)     203
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6    3 (13%)     141
  clusterin isoform 1                                                       42716297    58    6.2    3 (10%)     117
  **Sample NA4**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2    10(76%)    22296
  semenogelin II precursor                                                   4506885    65     9    16 (30%)    11486
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   13 (33%)    3038
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   14 (67%)    3631
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7   11 (38%)    3260
  lactotransferrin                                                          54607120    80    8.5   16 (45%)    2926
  prosaposin isoform a preproprotein                                        11386147    59     5     5 (20%)     773
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    3 (39%)     533
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3    4 (12%)     506
  extracellular matrix protein 1 isoform 1 precursor                         4758236    62    6.2    4 (17%)     454
  beta 2 microglobulin precursor                                             4757826    13     6     2 (21%)     388
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    3 (29%)     351
  cystatin S precursor                                                       4503109    16    4.9    5 (48%)     321
  cystatin C precursor                                                       4503107    16     9     2 (26%)     280
  cathepsin D preproprotein                                                  4503143    45    6.1    2 (11%)     200
  cathepsin B preproprotein                                                  4503139    38    5.8    2 (10%)     186
  carboxypeptidase E preproprotein                                           4503009    53     5     3 (11%)     162
  **Sample OA1**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2   12 (77%)    22670
  semenogelin II precursor                                                   4506885    65     9     19(32%)    13764
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   15 (27%)    6586
  albumin preproprotein                                                      4502027    71    5.9   26 (51%)    7715
  lactotransferrin                                                          54607120    80    8.5   28 (54%)    5063
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   11 (64%)    3309
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    9 (40%)    3298
  ankyrin repeat domain 11                                                  56676397    299   6.7    3 (1%)     1056
  PREDICTED: mucin 6, gastric isoform 1                                     89033736    185   6.3   10 (14%)     808
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    7 (70%)     635
  clusterin isoform 1                                                       42716297    58    6.2    4 (13%)     512
  fibronectin 1 isoform 2 preproprotein                                     47132551    269   5.3    10 (7%)     503
  extracellular matrix protein 1 isoform 1 precursor                         4758236    62    6.2    5 (28%)     420
  prosaposin isoform a preproprotein                                        11386147    59     5     4 (18%)     407
  prostatic acid phosphatase precursor                                       6382064    44    5.8    9 (28%)     365
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    4 (35%)     337
  beta 2 microglobulin precursor -- 1 peptide                                4757826    13     6     1 (18%)     262
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3    4 (12%)     242
  transferrin                                                                4557871    79    6.8    3 (4%)      211
  cathepsin D preproprotein                                                  4503143    45    6.1    2 (11%)     206
  cystatin C precursor                                                       4503107    16     9     5 (52%)     199
  cystatin S precursor                                                       4503109    16    4.9    6 (68%)     198
  secretory leukocyte peptidase inhibitor precursor −1 peptide               4507065    15    9.1    1 (18%)     175
  carboxypeptidase E preproprotein                                           4503009    53     5     2 (8%)      123
  galectin 3 binding protein                                                 5031863    66    5.1    3 (8%)      105
  cathepsin B preproprotein                                                  4503139    38    5.8    2 (12%)     95
  expressed in prostate and testis                                          19923082    14    8.2    1 (10%)     86
  macrophage migration inhibitory factor -- 1 peptide                        4505185    12    7.7    1 (9%)      84
  prostaglandin (H2) D-isomerase −1 peptide                                 32171249    21    7.6    1 (8%)      75
  **Sample OA2**                                                                                               
  prolactin-induced protein                                                  4505821    16    8.2    8 (51%)    13511
  semenogelin II precursor                                                   4506885    65     9    11 (18%)    6235
  albumin preproprotein                                                      4502027    71    5.9   10 (23%)    1848
  cystatin S precursor                                                       4503109    16    4.9    3 (28%)     522
  prostate specific antigen isoform 4 preproprotein                         71834855    24     7     4 (25%)     354
  prosaposin isoform a preproprotein                                        11386147    59     5     1 (2%)      324
  clusterin isoform 1                                                       42716297    58    6.2    3 (10%)     308
  mucin 6, gastric isoform 1                                                89033736    185   6.3    2 (1%)      306
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    4 (17%)     291
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    3 (38%)     184
  ankyrin repeat domain 11                                                  56676397    299   6.7    3 (1%)      133
  carboxypeptidase E preproprotein                                           4503009    53     5     2 (8%)      121
  lactotransferrin precursor                                                54607120    80    8.5    3 (9%)      115
  extracellular matrix protein 1 isoform 1 precursor                         4758236    62    6.2    1 (5%)      108
  galectin 3 binding protein                                                 5031863    66    5.1    1 (2%)      98
  cathepsin D preproprotein                                                  4503143    45    6.1    2 (13%)     95
  lactamase, beta isoform a                                                 26051231    61    8.7    2 (10%)     90
  prostatic acid phosphatase precursor                                       6382064    44    5.8    1 (4%)      78
  **Sample ON**                                                                                                
  prolactin-induced protein                                                  4505821    16    8.2    9 (69%)    33212
  semenogelin II precursor                                                   4506885    65     9    20 (35%)    10703
  semenogelin I isoform b preproprotein                                     38049014    45    9.2   17 ((38%)   2722
  albumin preproprotein                                                      4502027    71    5.9   25 (52%)    9519
  prostate specific antigen isoform 1 preproprotein                          4502173    29    7.6   14 (62%)    6487
  zinc alpha-2-glycoprotein 1                                                4502337    34    5.7    9 (38%)    5967
  lactotransferrin precursor                                                54607120    80    8.5    18(40%)    3770
  serine proteinase inhibitor, clade A, member 1                            50363217    46    5.3    4 (15%)    1138
  prosaposin isoform a preproprotein                                        11386147    59     5     6 (26%)    1014
  epididymal secretory protein E1 precursor                                  5453678    16    7.5    3 (39%)     937
  tissue inhibitor of metalloproteinase 1 precursor                          4507509    23    8.4    2 (19%)     866
  extracellular matrix protein 1 isoform 1 precursor                        221316614   62    6.2    3 (12%)     637
  beta 2 microglobulin precursor                                             4757826    13     6     2 (21%)     633
  mucin 6, gastric                                                          151301154   263   7.2    5 (5%)      407
  fibronectin 1 isoform 3 preproprotein                                     16933542    262   5.4    2 (1%)      352
  cathepsin D preproprotein                                                  4503143    45    6.1    2 (11%)     334
  cystatin C precursor                                                       4503107    16     9     3 (26%)     320
  carboxypeptidase E preproprotein                                           4503009    53     5     3 (11%)     172
  clusterin isoform 1                                                       42716297    58    6.2    2 (7%)      147
  acid phosphatase, prostate short isoform precursor                         6382064    44    5.8    3 (8%)      132
  secretory leukocyte peptidase inhibitor precursor                          4507065    15    9.1    2 (42%)     123
  protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor    104487006   218   6.1    4 (3%)      112

![**Broad categorical analysis of proteomics data.** Differentially expressed proteins list encompasses proteins that overlap with other categories (common, unique, low abundant and significant) of proteins.](1477-7827-11-38-1){#F1}

![**Venn diagram showing distribution of 20 differentially expressed proteins.** This was based on the NSC ratio cut-off \>2 across 3 samples, NA, OA, and ON in comparison to the baseline NN sample.](1477-7827-11-38-2){#F2}

###### 

Detailed list of classification of 35 proteins based on their presence, abundance, and differential expression

  **No.**   **Protein Names**                                                         **NCBI Accession No.**   **UniProt Accession No.**   **No. of samples**   **Proteins present in groups**   **Low abundant proteins (SC ≤ 10)**   **Differentially Expressed Proteins (in NA, OA, and ON) compared to NN**   **Significant proteins in groups**
  --------- ------------------------------------------------------------------------ ------------------------ --------------------------- -------------------- -------------------------------- ------------------------------------- -------------------------------------------------------------------------- ------------------------------------
  1         prolactin-induced protein                                                        4505821                    P12273                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  2         semenogelin II precursor                                                         4506885                    Q02383                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  3         albumin preproprotein                                                            4502027                    P02768                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  4         lactotransferrin                                                                 54607120                   P02788                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  5         epididymal secretory protein E1 precursor                                        5453678                    P61916                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  6         extracellular matrix protein 1 isoform 1 precursor                              221316614                   Q16610                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  7         prosaposin isoform a preproprotein                                               11386147                   P07602                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  8         cathepsin D preproprotein                                                        4503143                    P07339                     12             NN(5), NA(4), OA(2), ON(1)                                                                                                                                NN, NA, OA, ON
  9         prostate specific antigen isoform 1 preproprotein                                4502173                    Q546G3                     12             NN(5), NA(4), OA(2), ON(1)                                                                           ↑ in OA                                              NN, NA, OA, ON
  10        zinc alpha-2-glycoprotein 1                                                      4502337                    P25311                     12             NN(5), NA(4), OA(2), ON(1)                                                                           ↑ in ON                                              NN, NA, OA, ON
  11        clusterin isoform 1                                                              42716297                   P10909                     12             NN(5), NA(4), OA(2), ON(1)                  Low in ON                                                ↓ in ON                                                NN, NA, OA
  12        mucin 6, gastric                                                                151301154                   Q6W4X9                     11             NN(4), NA(4), OA(2), ON(1)                                                                           ↓ in NA                                              NN, NA, OA, ON
  13        cystatin S precursor                                                             4503109                    P01036                     11             NN(4), NA(4), OA(2), ON(1)                  Low in ON                                            ↓ in NA, OA, ON                                            NN, NA, OA
  14        galectin 3 binding protein                                                       5031863                    Q08380                     11             NN(5), NA(3), OA(2), ON(1)              Low in OA and ON                                           ↓ in OA, ON                                                NN, NA
  15        semenogelin I isoform b preproprotein                                            38049014                   P04279                     10             NN(3), NA(4), OA(2), ON(1)                                                                           ↑ in OA                                              NN, NA, OA, ON
  16        prostatic acid phosphatase precursor                                             6382064                    P15309                     10             NN(4), NA(3), OA(2), ON(1)                  Low in ON                                               ↓in NA, ON                                              NN, NA, OA
  17        cystatin C precursor                                                             4503107                    P01034                     9              NN(4), NA(3), OA(1), ON(1)                                                                            ↓in OA                                              NN, NA, OA, ON
  18        tissue inhibitor of metalloproteinase 1 precursor                                4507509                    Q6FGX5                     8              NN(3), NA(3), OA(1), ON(1)                                                                           ↑ in ON                                              NN, NA, OA, ON
  19        beta 2 microglobulin precursor                                                   4757826                    P61769                     8              NN(3), NA(3), OA(1), ON(1)                  Low in OA                                           ↓ in OA; Up in ON                                           NN, NA, ON
  20        DJ-1 protein                                                                     31543380                   Q99497                     6                 NN(2), NA(3), ON(1)                                                                             ↑ in NA, ON                                              NN, NA, ON
  21        ankyrin repeat domain 11                                                         56676397                   Q6UB99                     4                 NA(1), OA(2), ON(1)                  Low in NA and ON                                           ↓ in OA, ON                                                  OA
  22        orosomucoid 1 precursor                                                         167857790                   P02763                     2                     NN(2), NA(1)                         Low in NA                                                 ↓in NA                                                    NN
  23        serine proteinase inhibitor, clade A, member 1                                   50363217                   P01009                     8              NN(3), NA(3), OA(1), ON(1)                                                                     ↑ in NA,ON; ↓ in OA                                          NA, OA, ON
  24        transferrin                                                                      4557871                    Q06AH7                     6                 NN(2), NA(3), OA(1)                    Low abundant                                             ↑ in NA, OA                                                 NONE
  25        secretory leukocyte peptidase inhibitor precursor                                4507065                    P03973                     5                 NN(1), NA(3), OA(1)                    Low abundant                                             ↑ in NA, OA                                                 NONE
  26        ubiquitin and ribosomal protein S27a precursor                                   4506713                    P62979                     4                 NN(2), NA(1), OA(1)                    Low abundant                                             ↓ in NA, OA                                                 NONE
  27        protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor          104487006                   Q13332                     4                 NN(1), NA(2), ON(1)                    Low abundant                                             ↑ in NA, ON                                                 NONE
  28        acidic epididymal glycoprotein-like 1 isoform 1 precursor                        25121982                   P54107                     3                     NN(2), NA(1)                       Low abundant                                                ↓in NA                                                   NONE
  29        prostaglandin H2 D-isomerase                                                     32171249                   P41222                     5                 NN(2), NA(2), OA(1)                    Low abundant                                                                                                         NONE
  30        cathepsin B preproprotein                                                        4503139                    P07858                     6                     NN(3), NA(3)                       Low abundant                                                                                                         NONE
  31        expressed in prostate and testis                                                 19923082                   Q8WXA2                     4                 NN(2), NA(1), OA(1)                    Low abundant                                                                                                         NONE
  32        orosomucoid 2                                                                    4505529                    P19652                     1                        NN(1)                           Low abundant                                                                                                         NONE
  33        CD177 molecule                                                                  110735433                   Q8N6Q3                     3            NA(1), OA(1), ON(1n with (1))               Low abundant                                                                                                         NONE
  34        carboxypeptidase E preproprotein                                                 4503009                    P16870                     9              NN(3), NA(3), OA(2), ON(1)              Low in OA and ON                                                                                                      NN, NA
  35        fibronectin 1 isoform 2 preproprotein                                            47132551                   P02751                     10             NN(4), NA(4), OA(1), ON(1)                  Low in ON                                                                                                       NN, NA, OA

NN = normal sperm count and normal morphology; NA = normal sperm count and abnormal morphology; ON = oligozoospermia and normal morphology; OA = oligozoospermia and abnormal morphology; number in the parenthesis indicates the number of samples.

Identification of the common proteins
-------------------------------------

Our analyses revealed a set of 11 proteins that were common to all the samples in the 4 groups (Table [2](#T2){ref-type="table"}). Prolactin induced protein (PIP), semenogelin II (SgII) precursor, albumin preprotein, lactotransferrin, epididymal secretory protein E1 precursor, extracellular matrix protein 1 isoform 1 precursor, prosaposin isoform A preprotein, cathepsin D preprotein, prostate specific antigen isoform 1 preprotein, zinc alpha-2 glycoprotein 1, and clusterin isoform 1 were the common proteins identified.

Identification of differentially expressed proteins
---------------------------------------------------

As shown in Figure [1](#F1){ref-type="fig"}, the DEP list encompassed proteins that overlapped with other categories (common, unique, low abundant and significant). The common proteins that were also differentially expressed included prostate specific antigen isoform I preprotein; zinc alpha-2-glycoprotein 1 and clusterin isoform 1. Five low abundant proteins (transferrin; secretory leukocyte peptidase inhibitor precursor; ubiquitin and ribosomal protein S27a precursor; protein tyrosine phosphatase receptor type, sigma isoform 1 precursor, and acidic epididymal glycoprotein-like 1 isoform 1 precursor) were included as differentially expressed because their NSC ratio comparison met the 2-fold cutoff criteria. Of the 20 differentially expressed proteins, mucin 6, gastric; orosomucoid 1 precursor and acidic epididymal glycoprotein-like isoform 1 precursor were unique proteins that were down regulated in the NA group. The proteins identified as unique and upregulated in the OA group were: prostate specific antigen isoform 1 preprotein; semenogelin I isoform b preprotein. Cystatin C precursor was found to be downregulated in the OA group. The ON group showed an upregulation of two unique proteins (zinc alpha-2 glycoprotein 1 and tissue inhibitor of metalloproteinase 1 precursor); while clusterin 1 was downregulated in this group.

Some unique proteins were absent in some of the groups but were differentially expressed in other groups. These proteins included the DJ-1 protein, which was absent in the OA groups, whereas the ankyrin repeat domain 11 was absent in the NN group. Also included in this category was orosomucoid 1 precursor, which was found in significant abundance in the NN samples but in low abundance in NA sample.

Identification of the low abundant proteins
-------------------------------------------

Many of the identified proteins were low abundant proteins (SC ≤10) (Table [2](#T2){ref-type="table"}). Some of these proteins were restricted to a particular group while they were absent in other groups. Transferrin, secretory leukocyte peptidase inhibitor precursor, ubiquitin and ribosomal protein S27 a precursor, prostaglandin H2 D isomerase were some of the proteins that were absent in ON group. The CD177 molecule was absent only in the NN group; while orosomucoid 2 was present only in the NN. Protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor and acidic epididymal glycoprotein - like 1 isoform 1 precursor protein were absent in the OA group.

Cellular distribution and significant biological processes for proteins in four groups
--------------------------------------------------------------------------------------

The functional analysis revealed that most of the significant proteins in each of the four groups (NN, NA, OA, and ON) had a predominant cellular distribution in the extracellular region followed by their presence in the intracellular organelles (Figure [3](#F3){ref-type="fig"}). The distribution of proteins in the NA group was comparable in most of the cases to the NN group but was different from the ON and OA groups. The OA group showed only \~15% of the proteins localized in the plasma membrane region compared to the other groups, with the maximum number of proteins (\~20%) localized in the lysosomal and vacuolar regions. The ON group showed the least distribution of proteins in the nuclear region compared to the extracellular region.

![**Functional annotations from consolidated findings using publicly available software tools (GO term mapper, GO term finder, UniProtKB, STRAP, BioGPS) and proprietary pathway software packages (Ingenuity Pathway Analysis and Metacore™) showing cellular distribution of significant proteins in NN, NA, OA, and ON groups.**](1477-7827-11-38-3){#F3}

The functional analysis of the significant proteins in each of the groups revealed that most of the proteins involved in the biological process were regulatory in function (Figure [4](#F4){ref-type="fig"}). Based on the distribution pattern of the regulatory proteins, the OA groups showed the least involvement of proteins (60%) in regulation compared with 70% - 75% seen in the NN, NA and ON groups. A smaller number of proteins were involved in other functional processes such as protein complex assembly, cell morphogenesis, membrane organization, protein maturation and trafficking in all the 4 groups. Interestingly, none of the proteins in the ON group were involved in any of these processes. Importantly, of all the major processes represented, the OA groups showed the lowest distribution of signal transduction proteins (15%) and had little or no role in neurological system processing, membrane organization and protein maturation.

![**Functional annotations from consolidated findings using publicly available software tools (GO term mapper, GO term finder, UniProtKB, STRAP, BioGPS) and proprietary pathway software packages (Ingenuity Pathway Analysis and Metacore™) showing biological processes of significant proteins in NN, NA, OA and ON group.**](1477-7827-11-38-4){#F4}

Comparison of cellular distribution and biological processes amongst the common, DEP, and low abundant proteins
---------------------------------------------------------------------------------------------------------------

A detailed evaluation of the cellular localization of the common, DEP and low abundant proteins is shown in Figure [5](#F5){ref-type="fig"}. A higher distribution of the common proteins was seen in the majority of cellular compartments compared to DEP and low abundance proteins. The extracellular region showed the highest distribution (91%) of the common proteins whereas they were absent in the ribosomal and endosomal regions. Higher distribution of differentially expressed proteins was seen in the cytosolic and Golgi regions compared to the common or low abundance proteins. The low abundant proteins were absent in the protein complex and secretory granular region but their localization was found to be high in the nuclear and endosomal regions.

![**Functional annotations from consolidated findings using publicly available software tools (GO term mapper, GO term finder, UniProtKB, STRAP, BioGPS) and proprietary pathway software packages (Ingenuity Pathway Analysis and Metacore™) showing comparison of cellular distribution amongst the proteins in Common, DEP, and Low abundant category.**](1477-7827-11-38-5){#F5}

A comparative analysis of the proteins involved in various biological processes in the three groups are shown in Figure [6](#F6){ref-type="fig"}. The proteins commonly expressed in all 4 groups played a significant role in many of the biological processes such as cellular development, molecular transport, and stress response, interactions with cells and organisms, cellular processes and in processes relating to the immune system. Compared with the common proteins, DEP were comparable for the regulatory processes, but were reduced in all biological processes. Higher distribution was seen in protein metabolic process, vesicle mediated transport, defense response and cellular protein modification process. The low abundant proteins were seen to be involved mainly in protein metabolism, vesicle-mediated transport and defense response.

![**Functional annotations from consolidated findings using publicly available software tools (GO term mapper, GO term finder, UniProtKB, STRAP, BioGPS) and proprietary pathway software packages (Ingenuity Pathway Analysis and Metacore™) showing Comparison of Biological Processes amongst the proteins in Common, DEP, and Low abundant category.**](1477-7827-11-38-6){#F6}

Pathways and network analysis using IPA and metacore™
-----------------------------------------------------

Based on the dataset derived from common, DEP and low abundance proteins, pathways, biological functions and networks of interactions were derived utilizing the two proprietary pathway packages, IPA and Metacore™. The important processes affected by common proteins were lipid metabolism (epididymal secretory protein E1 precursor, prosaposin isoform A preprotein, clusterin isoform 1, lactotransferrin and cathepsin D preprotein), cell death and survival (cathepsin D preprotein, lactotransferrin, clusterin isoform 1, prosaposin isoform A preprotein and prostate specific antigen isoform 1 preprotein), and cellular development (clusterin isoform 1, prostate specific antigen isoform 1 preprotein, lactotransferrin, extracellular matrix protein 1 isoform 1 precursor, cathepsin D preprotein and epididymal secretory protein E1 precursor).

The important processes affected by DEP showed a higher involvement in carbohydrate metabolism and nephrosis (ankyrin repeat domain 11, beta 2 microglobulin (B2MG) precursor, clusterin isoform 1, cystatin C precursor, prostate specific antigen isoform 1 preprotein, DJ-1 protein, protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor, transferrin). The major pathways involved are proteolysis (extracellular matrix; ECM), remodeling and connective tissue degradation, immune response, clathrin-mediated endocytosis signaling, lipid antigen presentation by CD1, and intrinsic prothrombin activation pathway. Similarly, in the low abundant proteins the top biological functions included the cellular development, growth proliferation, DNA replication, recombination, and repair (prostaglandin (H2) D-isomerase, protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor and transferrin).

We also studied the major biological functions of the DEP in each of the 3 groups and found that free radical scavenging was the topmost function in the NA group, while cell-to-cell signaling and interaction were seen in all 3 groups. Genes that encode for 7 differentially expressed proteins (cysteine-rich secretory protein 1, clusterin, prostatic acid phosphatase (PAP), mucin 6, prostate specific antigen (PSA), zinc alpha-2-glycoprotein 1, and DJ-1) are known to be regulated by androgen receptor. The transcriptional network showed the activation of prostate induction by the androgen receptor signaling pathway. DJ-1 protein, protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor and transferrin were observed to interact with other proteins in the pathway database and affect processes related to cellular function and maintenance. Similarly, in the OA group, prostate specific antigen isoform 1 preprotein and transferrin formed the topmost network, encompassing key processes such as gene expression, tissue morphology and cell cycle. The ON group showed immunological disease, antigen presentation, cell-to-cell signaling and interaction (B2MG precursor, DJ-1 protein, receptor type, sigma isoform 1 precursor) as the key processes affected in its topmost network

Discussion
==========

Seminal plasma is a mixture of secretions of several male accessory glands, including prostate, seminal vesicles, epididymis and Cowper's gland. Prostate gland is a major contributor to seminal plasma. It is a very rich source of protein with concentration ranges from 35 to 55 g/l \[[@B9],[@B10]\]. It provides a safe environment for spermatozoa to carry out their physiological functions. Understanding the protein profile of human seminal plasma is important because it has a profound impact on sperm physiology and thus may affect sperm functioning \[[@B31]\].

In this novel study, we identified 35 proteins based on SEQUEST scoring in the seminal plasma of men with varying semen parameters and categorized them into common, differentially expressed, and low abundant proteins. The large variation in the number of proteins identified by any given technique depends mainly on the sample preparation and mass spectrometry technology available \[[@B32]-[@B36]\]. Recently, the LTQ-Orbitrap mass spectrometer has become the cutting-edge instrument for LC/MDS/MS based approaches to characterize the seminal proteome. In our study, we used in-solution digestion of proteins with the online LC-MS system. Seminal plasma from different subsets was pooled to form 4 distinct study groups. There are numerous studies in the proteomic literature that refer to the benefits of pooling samples where it may not be feasible to analyze individual samples due to limitations of the sample or the study design \[[@B8],[@B17],[@B37],[@B38]\].

Of the 11 proteins found in all the samples, 9 were associated with sperm function, and the common proteins comprised the majority of the secretions of the prostate gland, the seminal vesicles and epididymis. Some of the proteins or their isoforms detected in the seminal plasma were zinc alpha-2-glycoprotein 1, clusterin, lactotransferrin, prostate specific antigen. These were similar to those reported by Utleg et al. \[[@B39]\].

Prostate specific antigen is a serine protease that cleaves semenogelin by hydrolysis and thus liquefies the semen coagulum and facilitates sperm motility and capacitation \[[@B40],[@B41]\]. Our study showed that prostate specific antigen isoform I preprotein was one of the common proteins, thus indicating its importance in all the 4 groups. Prolactin-induced protein (PIP) and Sg II are important common proteins that have a profound impact on sperm physiology. PIP has specificity to fibronectin and constitutes about 1% of seminal coagulum \[[@B42]\]. It may play a vital role in fibronectin breakdown during liquefaction. Viscous samples have been reported to show reduced amounts of PIP and PIP precursor, which may also be a contributory factor towards incomplete liquefaction \[[@B43]\]. Both Sg I and II are the major proteins of the coagulum. They represent 20-40% of the seminal plasma proteins. Studies have shown increased Sg concentrations in asthenozoospermic men \[[@B44],[@B45]\]. Our study showed that both prolactin and semenogelin II were in all samples but they were not differentially expressed, indicating that men with low sperm count or abnormal morphology may not be affected by these proteins---a conclusion also made by Milardi et al. \[[@B18]\].

Epididymal secretory protein E I precursor, albumin preprotein, lactotransferrin, extracellular matrix protein E1 precursor, prosaposin isoform a preprotein, cathepsin D preprotein were some of the commonly expressed proteins that were not differentially expressed in any of the groups, suggesting that these proteins may not play a significant role in sperm concentration or morphology.

The highest percentage of the common proteins was seen in the extracellular region (Figure [5](#F5){ref-type="fig"}). Human seminal plasma proteins can bind to sperm surface proteins in the ejaculate and form a protective layer around the spermatozoon \[[@B12]\] as well as a sperm reservoir in the oviduct \[[@B46]\]. It is likely that the extracellular origin of most of the common proteins may play a key role in the binding activity of the proteins. The absence of common proteins in the ribosomal and endosomal region (Figure [5](#F5){ref-type="fig"}) suggests a relatively low involvement in protein metabolism, as also seen by the low distribution of common proteins in the 'protein metabolic process' category, (Figure [6](#F6){ref-type="fig"}). Zinc alpha-2 glycoprotein and clusterin play a role in signal transduction while lactotransferrin is a transport and structural protein \[[@B39]\]. Prostate specific antigen has been shown to have enzymatic activity. Our results show a high distribution of signal transducing protein among the common proteins, suggesting the importance of clusterin, isoform 1 and zinc alpha-2 glycoprotein 1 (Figure [6](#F6){ref-type="fig"}). This was also confirmed from the pathway and network analysis, which also highlighted the role these proteins play in molecular transport, cell death and survival and lipid metabolism.

A clear overlap was observed for some of the differentially expressed proteins. These included the prostate specific antigen isoform 1 preprotein, zinc alpha 2 glycoprotein 1, and clusterin isoform 1. While semenogelin II precursor was seen in common proteins, the semenogelin I isoform b preprotein was found to be upregulated in the OA group. This suggests that it may contribute to the low motility seen in this group compared to other groups.

Clusterin isoform was downregulated in the ON group. This is an interesting finding, given that clusterin isoform 1 has been shown to be downregulated in prostate cancer. The proteome of the seminal fluid is largely attributed to secretions from the prostate gland, and approximately 10% is contributed by the testis and the epididymis \[[@B8]\].

Prostate gland is a major contributor to seminal plasma. Furthermore, one of the proteins - prostatic acid phosphatase (PAP) was significantly increased in azoospermic men compared to oligozoospermic men and asthenozoospermic men \[[@B10]\]. In our study, PAP levels were down regulated in the NA and ON groups. PAP levels have also been reported to correlate with sperm concentration \[[@B47]-[@B49]\]. Patients with severe oligozoospermia (\<1 × 10^6^) were also shown to have increased levels of seminal PAP \[[@B50]\]. PAP is produced in the prostate gland and is present in the seminal fluid at a concentration of 1 mg/mL. It is an important tumor marker and acts as a negative growth regulator in prostate cancer \[[@B51]\].

A proteomic analysis of seminal fluid, rather than blood, has been proposed as as a better starting point to identify changes that may serve as specific and sensitive markers of prostate dysfunction \[[@B17]\]. These authors identified more than 100 proteins such as PSA, semenogelin I and II, clusterin etc. which have been shown to affect sperm quality.

The increased expression of semenogelin I in the OA group suggests that the accessory gland secretions have a profound impact on oligozoospermic men with abnormal morphology. Wang et al. reported semenogelin I and mucin were not differentially expressed and therefore had no effect in asthenozoospermic men \[[@B21]\]. Our study also included the differentially expressed proteins, especially DJ-1 secreted from the testis, epididymis and prostate \[[@B39],[@B52]\]. DJ-1 has a high level of expression in the testis. We found DJ-1 to be overexpressed in the NA and ON groups. We also documented that orosomucoid 1 precursor was downregulated in the NA group whereas expression of orosomucoid 2 was comparable in all groups, though it was present in low abundance. However, Wang et al. reported the overexpression of orosomucoid 1 and orosomucoid 2 in asthenozoospermic patients \[[@B21]\]. These proteins have also been found in high abundance in post vasectomy patients \[[@B8]\].

B2MG was found to be under-expressed in OA while over-expressed in the ON samples. B2MG is present in all nucleated cells. It is one of the two polypeptide chains of the major histocompatiblity complex (MHC) class I molecule. In humans B2MG is coded by the B2M gene. It is a marker of cellular immune system. It is a naturally occurring protein and can detect certain types of tumor cells in the blood and kidney, and some inflammatory and autoimmune disorders \[[@B53],[@B54]\]. In our study as well as that reported by Fung et al. \[[@B17]\], many of the proteins in the seminal plasma were identified to be forerunners of prostate disease, suggesting a pathogenic role for B2MG \[[@B55],[@B56]\]. Similarly high levels of B2MG were reported in the seminal plasma of azoospermic men compared to controls \[[@B10],[@B57],[@B58]\]. An inverse correlation was reported between B2MG levels in seminal fluid and sperm count \[[@B10]\].

Similary, we reported the underexpression of galectin 3 binding protein in oligozoospermic group. Galectin-3 is a carbohydrate-binding protein whose expression level has been shown to correlate with metastatic potential in a number of different types of tumors. Galectin-3 is downregulated in prostate cancer. The altered downregulation pattern of galectin-3 observed between tumor stages suggests different roles for galectin-3 in the progression of prostate cancer \[[@B59]\].

TIMP 1 can inhibit tumor growth, invasion and metastasis through their matrix metalloproteinases (MMP) inhibitory activity \[[@B60],[@B61]\]. TIMPs play an inhibitory role, and any imbalance between the two may result in progression of the disease \[[@B62]\]. TIMP was found to be over-expressed in the ON group.

Amongst the proteins that were uniquely under-expressed in the OA group was ankyrin repeat domain 11 (ANKRD11). Ankyrins function as adaptor proteins \[[@B63],[@B64]\] and play a vital role in membrane skeleton organization, ionic transport, maintenance of cell polarity as well as cell-cell adhesion regulation. Data suggest that ANKRD11 may act as a tumor suppressor \[[@B65]\]. It's presence in the semen samples has not been well documented, but it is likely that its overexpression in oligozoospermic men may play a role in apoptosis. Clusterin isoform 1 can be both pro- and antiapoptotic depending upon the isoform expressed \[[@B66],[@B67]\]. It plays a key role in signal transduction and is involved in apoptosis of spermatocytes, sperm maturation, and spermiation. Low signal transducing proteins were seen in the OA group compared with the other groups, as shown in Figure [4](#F4){ref-type="fig"}.

Compared with the proteins involved in stress response, as elucidated from GO annotations (Figure [4](#F4){ref-type="fig"}), the NA and ON groups had a higher distribution of stress proteins such as DJ-1 whereas a lower distribution of this protein was seen in OA group. DJ-1 protein is a multifunctional, highly conserved antioxidant protein and is upregulated in hyperglycemia \[[@B68],[@B69]\]. It is mainly involved in the control of oxidative stress and is downregulated in the seminal plasma of asthenozoospermic men \[[@B21]\]. DJ-1 is activated in stress conditions, but with higher levels of stress (as seen in OA), there is depletion of antioxidant levels and low expression of DJ-1 protein. Furthermore, the major biological function that comes into focus through IPA in the NA group is free-radical scavenging activity. This further supports the fact that DJ-1 was activated in the NA group. Significant proteins were distributed in the lysosomal and vacuolar regions in higher amounts in the OA group (Figure [3](#F3){ref-type="fig"}), suggesting that proteins with phagocytic activity may be activated in stress conditions. Previous studies have reported reduced levels of DJ-1 in sperm in response to toxic exposure of male rats to ornidazole and epichlorhydrin \[[@B70]\].

Utleg et al. categorized prostatic acid phosphatase (PAP) precursor as an enzymatic protein, and the presence of this protein in our study suggests that it plays a similar role \[[@B39]\]. The distribution pattern of immune system response in all the groups is shown in Figure [4](#F4){ref-type="fig"}. It is likely that B2MG is the major protein in immune response and that low levels of this protein are seen in stress conditions. Low distribution of B2MG in DEP compared to normal and low abundant proteins further suggests that in addition to B2MG, there are other proteins that also play a key role in immune system processes. We further validated this observation from the pathway analysis, which showed that that the common protein prosaposin isoform, a preprotein, is involved in lipid antigen presentation by CD1.

We observed overlapping of differentially expressed proteins with the low abundant proteins in our study. These included transferrin, secretory leukocyte peptidase inhibitor precursor, ubiquitin and ribosomal protein S27a precursor, protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor and acidic epidiymal glycoprotein- like 1 isoform 1 precursor. Of these proteins, protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor, acidic epididymal glycoprotein-like isoform 1 precursor were amongst the low abundant proteins. Protein tyrosine phosphatase, receptor type, sigma isoform 1 precursor were upregulated while acidic epididymal glycoprotein-like isoform 1 precursor was down regulated in the NA group. The acidic epididymal glycoprotein like I isoform I precursor is a member of the cysteine - rich secretory protein (CRISP) family and is encoded by the gene CRISP-I. It is expressed in the epididymis and is secreted into the epididymal lumen. It binds to the post acrosomal region of the head, where it may play a role in sperm-egg fusion. The reported low abundance of acidic epididymal glycoprotein like I isoform I precursor protein is concordant with the findings of Batruch et al. who also reported its low abundance in the seminal plasma of post vasectomy patients compared to controls \[[@B8]\].

Transferrin is one of the serum proteins that has been characterized in the seminal plasma, but its role in male infertility is unclear \[[@B20]\]. Our study showed this protein was present in low levels in the NN group but was up regulated in NA and OA groups. Prostaglandin H2 D isomerase, cathepsin B preprotein, orosomucoid 2 and the CD177 molecule were the low abundant proteins that were not differentially expressed in any of the groups. In our study, CD177 was absent in the NN group but present in all the other groups although they were not differentially expressed. Our findings are consistent with previous publications that reported low concentrations of CD177 in fertile men (control samples) compared to postvasectomy men \[[@B8]\] but are contrary to the findings of Wang et al. who reported upregulation of CD177 in asthenozoospermic patients \[[@B21]\]. Cathepsin B preprotein was present in the NN and NA groups, showing its specificity to the normal sperm count while prostaglandin H2 D isomerase was absent in the ON group. Cathepsin B preprotein found in the lysosomal region is a thiol protease believed to participate in intracellular degradation. It has also been implicated in tumor invasion and metastasis. The prostaglandin (H2) D-isomerase is expressed in the testis, epididymis and prostate and is secreted into the seminal fluid. It binds small non-substrate lipophilic molecules and may act as a scavenger for harmful hydrophobic molecules. The prostaglandin (H2) D-isomerase and cathepsin B protein are potentially involved in biological processes such as vesicle-mediated transport and defense response. The low abundant proteins showed a marked distribution in the extracellular region and may play a regulatory role. The major pathways in which the low abundant proteins were involved were prostanoid biosynthesis and eicosanoid signaling and acute phase response signaling, but the distribution of signal transduction proteins was decreased in low abundant proteins.

Conclusions
===========

In the present study, we have identified proteins that are common, unique, and differentially expressed in 4 study groups. Twenty proteins were differentially expressed in the seminal plasma of men with poor sperm quality. We have highlighted the distribution pattern of these proteins in cell organelles and described their biological processes. We have also illustrated the high involvement of proteins in cellular development signal transduction. The overexpression or underexpression of these proteins in the 4 groups illustrates their role in male infertility. Our findings from the bioinformatic analysis shows that stress proteins such as DJ-1 are differentially regulated and expressed in the different study groups, suggesting that some of these proteins may serve as a potential biomarkers in identifying the mechanistic role in men with poor sperm quality.
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